 |
 |
Hi, Barb. Your comments about the 20/20 "Parkinson's" piece were well-stated. I too was startled by the claim in the piece that the French team had apparently come up with this deep-brain-stimulation-for-PD as something ENTIRELY NEW and that it appeared, from how the piece was focused, to be a sort permanent symptomatic CURE. I thought that I had read info on the net, for quite some time now, that this technique had already been developed & tested elsewhere -- including, according to a March 14 PR Newswire press-release on the internet, by a US-based company called Medtronics; in that press-release (which I saved), the company claims that some 2,000 people in Europe, Canada, and Australia have already been implanted with Medtronics' deep-brain-stimulation system. And I also see that the release notes that an FDA panel had just approved testing of the Medtronics device for potential FDA approval for use in the United States. So I wonder: how could 20/20 have possibly excluded such significant information in its report? Wouldn't reportage on that particular device, and on exactly how those alleged 2,000 people are faring on it, qualify as being highly relevant to the topic? Something just doesn't seem to add up. - SJS